AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
InPractice Survey on the Treatment of Hypercholesterolemia
Completed
- Conditions
- Hypercholesterolemia
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2011-02-16
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2500
- Registration Number
- NCT00523796
- Locations
- 🇻🇳
Research Site, Hanoi, Vietnam
Esomeprazole And Symptomatic Response In Patients With Or Without An Elevated Risk For Non-Steroidal Anti-Inflammatory Drug (NSAID)-Associated GI Damage
Completed
- Conditions
- Heartburn
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2008-09-26
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1220
- Registration Number
- NCT00524329
The Effect of Lifestyle-Adjustments Prior to Medical Treatment on the Effect of Medical Treatment in Reflux Patients
Completed
- Conditions
- GERDQuality of Life
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2008-09-17
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 990
- Registration Number
- NCT00524251
- Locations
- 🇳🇱
Research Site, Zoetermeer, Netherlands
Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD
Completed
- Conditions
- GERD
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2009-07-17
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2717
- Registration Number
- NCT00524355
- Locations
- 🇻🇳
Research Site, Ho Chi Minh City, Vietnam
Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler
Completed
- Conditions
- Asthma
- First Posted Date
- 2007-09-03
- Last Posted Date
- 2009-07-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1254
- Registration Number
- NCT00524641
- Locations
- 🇻🇳
Research Site, Ho Chi Minh City, Vietnam
APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire)
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2007-08-31
- Last Posted Date
- 2011-05-20
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 862
- Registration Number
- NCT00523315
- Locations
- 🇰🇷
Reserach Site, Euijungbu-si, Gyunggi-do, Korea, Republic of
🇰🇷Research Site, Ulsan, Korea, Republic of
Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2007-08-31
- Last Posted Date
- 2010-01-26
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1200
- Registration Number
- NCT00523484
- Locations
- 🇰🇷
Research Site, Seoul, Songpa-gu, Korea, Republic of
Quetiapine Efficacy in Bipolar Depression Study
Completed
- Conditions
- Bipolar Depression
- First Posted Date
- 2007-08-31
- Last Posted Date
- 2008-10-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2000
- Registration Number
- NCT00523601
- Locations
- 🇰🇷
Research Site, Kyungki-do, Suwon-si, Korea, Republic of
Seroquel Long-Term NIS for Schizophrenia Patients
Completed
- Conditions
- SchizophreniaSchizoaffective Disorder
- First Posted Date
- 2007-08-31
- Last Posted Date
- 2008-10-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1000
- Registration Number
- NCT00523783
- Locations
- 🇰🇷
Research Site, Seoul, Songpa-gu, Korea, Republic of
Symbicort SMART (Symbicort Maintenance And Reliever Therapy)
Completed
- Conditions
- Asthma
- First Posted Date
- 2007-08-31
- Last Posted Date
- 2009-07-13
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2000
- Registration Number
- NCT00523679
- Locations
- 🇰🇷
Research Site, Seoul, Songpa-gu, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath